DropGenie

About

DropGenie makes tools for experiments on patient-derived cells. The PR Newswire release calls it a functional biology company and says it is based in Montreal and Boston. FinSMEs calls it Cambridge, MA-based. BetaKit says it is based in Montreal and Boston and that the team is split between offices in Montreal and Cambridge, Mass. The Raise Track Update says Cambridge, MA. Those cities do not agree, so this page does not store a city.

BetaKit says the company was founded in 2018. The release and FinSMEs do not state a founding year. This page stores 2018.

The release is timestamped Oct 26, 2026, 06:00 ET (10:00 UTC), so the round date is 2026-10-26. The issue's amount line says $5 million seed. The issue's description, the release, FinSMEs, and BetaKit call the financing Seed+ or seed-plus. This page uses seed, which is the stage on the amount line, and the round page records the Seed+ wording. The amount is $5 million USD. BetaKit also states a Canadian-dollar figure. That figure is not stored. The release states a fund size for BDC's Thrive Venture Fund. That figure is not stored.

The issue does not name a lead. The release says BDC Thrive Venture Fund invested alongside Skeleton Key and does not name a lead. FinSMEs does not name a lead. BetaKit says Skeleton Key had led. No lead is marked. The six named backers are participants.

Funding history

Investors

• BDC Thrive Venture Fund participant
• Skeleton Key participant
• Merck Global Health Innovation Fund participant
• CQDM participant
• Real Ventures participant
• Anges Quebec participant

Sources

Last verified: 2026-10-27

1. https://www.prnewswire.com/news-releases/dropgenie-secures-5-million-seed-financing-to-scale-functional-biology-platform-and-data-partnerships-302918853.html
   Type: funding announcement. Accessed 2026-10-27.
   PR Newswire release, Oct 26, 2026, 06:00 ET (10:00 UTC). Dateline MONTREAL. Says DropGenie secured $5 million in Seed+ financing. Says BDC Thrive Venture Fund invested alongside Skeleton Key, with Merck Global Health Innovation Fund, CQDM, Real Ventures, and Anges Quebec. Does not name a lead. The about line says the company is based in Montreal and Boston. A $350 million fund size in the release is not stored. This is the earliest timestamp read here, so the round date is 2026-10-26.
2. https://www.finsmes.com/2026/10/dropgenie-raises-5m-in-seed-funding.html
   Type: reputable publication. Accessed 2026-10-27.
   FinSMEs, October 26, 2026. Calls DropGenie a Cambridge, MA-based functional biology company and says it raised $5 million in Seed+ funding. Names the same six backers and does not name a lead. Says the company intends to use the funds to accelerate commercialization of its first product, expand customer engagement models, and expand its global footprint.
3. https://betakit.com/dropgenie-raises-5-million-usd-backed-by-bdc-to-speed-up-biological-discovery/
   Type: reputable publication. Accessed 2026-10-27.
   BetaKit, Madison McLauchlan, October 26, 2026. Says the company is based in Montreal and Boston and has offices in Montreal and Cambridge, Mass. Says BDC Capital's Thrive Fund joined a seed-plus financing that totals $5 million USD, and also states a Canadian-dollar figure that is not stored. Says Skeleton Key had led, alongside Merck Global Health Innovation Fund and CQDM, with Real Ventures and Anges Quebec. The issue does not name a lead, so no lead is marked. Says the company was founded in 2018.
4. https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-26/
   Type: other verified public source. Accessed 2026-10-27.
   Raise Track Update for 2026-10-26, Section 1. Amount line $5M (Seed). The description says a Cambridge, MA-based company raised $5 million in seed+ funding and names the same six backers. It does not name a lead. This page uses the amount line's stage, seed, and records that the description and the other sources say Seed+.